The pathologic hallmark of synucleinopathies (α-synuclein aggregation) and different syunclein strains associated with different disease phenotypes have led to ongoing research into biomarkers for early diagnosis and potential therapeutic strategies, and will be the focus of this review. The gene discussed is SNCA; the disease is synucleinopathy.